Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics
Cancer Letters · 2024-05 · 590 · 216847
DOI: 10.1016/j.canlet.2024.216847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-05. Verfasst von Yuxuan Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, No.6 Ankang Avenue, Guian New District, Guizh…. Hauptthemen laut MEDLINE: Tamoxifen, Mitochondrial Dynamics, Apoptosis, GTP Phosphohydrolases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tamoxifen (TAM) resistance presents a major clinical obstacle in the management of estrogen-sensitive breast cancer, highlighting the need to understand the underlying mechanisms and potential therapeutic approaches. We showed that dysregulated mitochondrial dynamics were involved in TAM resistance by protecting against mitochondrial apoptosis. The dysregulated mitochondrial dynamics were associated with increased mitochondrial fusion and decreased fission, thus preventing the release of mitochondrial cytochrome c to the cytoplasm following TAM treatment. Dynamin-related GTPase protein mitofusin 1 (MFN1), which promotes fusion, was upregulated in TAM-resistant cells, and high MFN1 expression indicated a poor prognosis in TAM-treated patients. Mitochondrial translocation of MFN1 and interaction between MFN1 and mitofusin 2 (MFN2) were enhanced to promote mitochondrial outer membrane fusion. The interaction of MFN1 and cristae-shaping protein optic atrophy 1 (OPA1) and OPA1 oligomerization were reduced due to augmented OPA1 proteolytic cleavage, and their apoptosis-promoting function was reduced due to cristae remodeling. Furthermore, the interaction of MFN1 and BAK were increased, which restrained BAK activation following TAM treatment. Knockdown or pharmacological inhibition of MFN1 blocked mitochondrial fusion, restored BAK oligomerization and cytochrome c release, and amplified activation of caspase-3/9, thus sensitizing resistant cells to apoptosis and facilitating the therapeutic effects of TAM both in vivo and in vitro. Conversely, overexpression of MFN1 alleviated TAM-induced mitochondrial apoptosis and promoted TAM resistance in sensitive cells. These results revealed that dysregulated mitochondrial dynamics contributes to the development of TAM resistance, suggesting that targeting MFN1-mediated mitochondrial fusion is a promising strategy to circumvent TAM resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, No.6 Ankang Avenue, Guian New District, Guizhou 561113, China; The High Efficacy Application of Natural Medicinal R…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, Y., Ren, S., Chen, X., Li, X., Chen, L., Zhao, S., Zhang, Y., Shen, X., & Chen, Y. (2024). Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics. Cancer Letters, 590, 216847. https://doi.org/10.1016/j.canlet.2024.216847
Vancouver
Song Y, Ren S, Chen X, Li X, Chen L, Zhao S, et al. Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics. Cancer Letters. 2024;590:216847. doi:10.1016/j.canlet.2024.216847
BibTeX
@article{Song2024,
author = {Song, Yuxuan and Ren, Shuang and Chen, Xingmei and Li, Xuhong and Chen, Lin and Zhao, Shijie and Zhang, Yue and Shen, Xiangchun and Chen, Yan},
title = {Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics},
journal = {Cancer Letters},
year = {2024},
volume = {590},
pages = {216847},
doi = {10.1016/j.canlet.2024.216847}
}
EUVIMED